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Histologic  studies  of rabbits  dying after  two  properly spaced intravenous 
injections  of  bacterial  endotoxin  reveal  a  deposition  in  certain  arterioles, 
capillaries, and venules of a  material that has been referred to as "fibrinoid" 
or "hyaline thrombi" (1). 
On the l~.,sis of histochemical observations, Booth et al.  (2) have suggested  that 
this material is derived from breakdown products of the walls of arterioles or arteries 
which  are presumably damaged primarily by exposure to the toxin. Most students 
of the Shwartzman reaction have preferred to describe the material as hyaline thrombi 
or "fibrinoid" with no commitment as to its origin.  Several observations have indi- 
cated that these are actually fibrin thrombi. Histologically the thrombi react with 
the  phosphotungstic  acid  hematoxylin, periodic aeid-Schiff,  and  Weigert's  stains, 
none of which is specific for fibrin but all of which react with fibrin. More importantly, 
it was demonstrated by Good and Thomas  (3)  and  Cluff  and Berthrong  (4)  that 
when the  animals' blood is rendered incoagulable  with heparin,  the generalized  as 
well as the local Shwartzman reaction cannot be elicited.  Brunson et al.  (5)  using 
an acid polysaccharide (liquoid),  shown  by Walton  (6)  to precipitate fibrinogen  in 
vitro, demonstrated that this material in combination with small amounts of bacterial 
endotoxin  also  was capable of producing a  pathologic sequence  that was entirely 
similar to  the generalized  Shwartzman reaction. Thomas  (7)  further noted  a  pre- 
cipitous drop in circulating fibrinogen  after the injection of liquoid.  With this back- 
ground he suggested that "fibrinoid" is derived from the circulating blood and that 
fibrinogen may play an important role in its formation. 
These  observations  suggest  that  the  manifestations  of  the  generalized 
Shwartzman  reaction  are  in  part  mediated  by one  or  more  episodes  of dis- 
seminated  intravascular  coagulation.  The  studies  reported  herein  on  the 
alterations  in the  hemostatic mechanism during the  development of the gen- 
eralized Shwartzman reaction were undertaken for the following reasons:- 
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1.  To determine whether there is a drop in the level of circulating fibrinogen 
after the injection of bacterial endotoxin, as noted by Thomas after the injec- 
tion of liquoid. 
2.  To compare the alterations in the blood coagulation system in this reac- 
tion  with  those  seen  in  other  experimental  conditions  such  as  intravenous 
thromboplastin  injection,  in  which  disseminated  intravascular  coagulation 
is the major pathologic consequence. 
3.  To determine whether alterations in the blood clotting mechanism could 
account  for  the  difference  in  location  and  extent  of  thrombosis  when  two 
spaced doses of endotoxin instead of one are given intravenously. 
Materials and Methods 
Hybrid female albino  rabbits  weighing 1 kg. were injected  with Shcar's  polysaccharide.  I 
Two doses  of  0.2  rag.  of  polysacclmridc  in  2.0  mL of  physiologic  saline  were injected  int  O the 
marginal ear vein  with a 24 hour interval  between the first  and second injection.  Control 
animals were injected  with saline  only.  Blood samples were obtained by cardiac puncture, 
using iodine  antisepsis,  at the following  times:  before  injection;  1 hour, 4 hours,  24 hours, 
25  hours,  28  hours,  and  48  hours  after  the  first  injection.  Three  groups of  animals  were  studied: 
(a) Control  group injected  with saline,  (b) animals given one injection  and followed  through 
the  48  hour  period;  and (c)  animals  given  2 injections  24  hours  apart  and  followed  through the 
48 hour period.  Three to four  mL of blood wcre drawn at each cardiac  puncture and the 
following  tests  done:-- 
A. White blood count. 
B. Piatelet  count by the  Rees-Ecker technique. 
C. Whole blood coagulation  time.  A modified  three  tube Lee-White procedure in silicone 
was used.  The test  was run at 37°C. and a solid  clot  in the third  tube was the end point. 
The needles,  syringes,  and tubes were siliconized  with General Electric  SC-87 drifilm. 
D. One stage  prothrombin time.  Blood was drawn into  plain  glass  tubes  containing  po- 
tossium  oxalate;  spun at  room temperature at 1500 r.p.m,  for  15  minutes and a one  stage  pro- 
thrombin time was done on the plasma using  simplastin  (Warner-Chilcott)  as the thrombo- 
plastic  agent. 
E. Thrombin clotting  times.  0.2  ml. of  oxalated  plasma was added to  0.2  ml.  of  a solution 
of  fibrinogen  (Cohn's  fraction  I).  To this  were added 0.2  ml. of  saline  containing  150,  200,  or 
250 #g. of  bovine thrombin; and the  dotting time of  the mixture was then measured. 
F. Fibrinogen  level.  The method described  by Ratnoff (8) was used. 
G. Fibrinogenolysis.  The method suggested  by Crosby (9) was used.  A fibrinogen  level  on 
one portion of the plasma sample was done immediately. A 1 ml. aliquot was diluted in saline 
and buffer in the same manner but placed in a 37°C. incubator for 2 hours. At the end of this 
time the fibrinogen was clotted and the amount determined in the usual manner. The differ- 
ence between the incubated and non-incubated fibrinogen levels has been taken as the amount 
of fibrinogenolysis. 
H. Fibrinolysis. Clotted whole blood was placed in the incubator for 48 hours at 37°C. and 
observed for destruction of the clot. 
The animals that died during the experiment were autopsied immediately and all others 
were sacrificed at the end of the 48 hour period and autopsied immediately. The tissues were 
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fixed in 10 per cent neutral formalin and paraffin sections were stained with hematoxylin and 
eosin, and phosphotungstic acid hematoxylin. 
OBSERVATIONS 
Histology.--Because of  the  variability of response  to  different endotoxins 
and  to  different concentrations  of  the  same  endotoxin,  it  is  necessary first 
to  define  in  histologic  terms,  the  extent and  locations of  the  intravascular 
thrombi under the conditions of the experiment. 
TABLE  I 
Lungs  Liver  Spleen  Kidneys 
1+* 
2+ 
3+ 
4+ 
Controls (21 animals)  1  0 
0  0 
0  0 
0  0 
i+ 
2+ 
3+ 
4+ 
Total..  14 (38 per cent) 
One injection (37 animals) 
4  .5 
2  10 
3  5 
0  ! 
9 (24 per cent)  21 (57 per cent)  6 (16 per cent) 
1+ 
2+ 
3+ 
4+ 
15 
11 
6 
2 
5 
4 
10 
5 
Two injections (45 animals) 
12  6 
8  14 
9  7 
2  2 
31 (69 per cent)  29 (64 per cent)  Total..  34 (76 per cent)  24 (53 per cent) 
* 1-F  Thrombosis in one capillary; 2+  many capillary and venular thrombi; 3+  ~/~ to 
of all capillaries or venules occluded by thrombi; 4+  Virtually all capillaries or venules 
contain thrombi. 
Although a complete autopsy was performed on each animal, pathologic changes ascribable 
to  the bacterial toxin were observed only in the lungs, liver, spleen, and kidney.  Areas of 
hemorrhage, necrosis, and inflammation were observed in the myocardium of the majority of 
animals but were undoubtedly related only to the needle puncture sites. The histologic sec- 
tions were examined for the presence of thrombi in capillaries, arterioles, and venules as well 
as for areas of necrosis. In this study necrosis was a  common accompaniment of the intra- 
vascular thrombi, but many animals dying shortly after the first or even the second injection 
showed only thrombosis with no necrosis. 
In  the lungs the thrombi were  found in  capillaries,  venules, and arterioles.  Occasional 
hemorrhages were observed in  the alveolar spaces but no infarcts were found.  There was 
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the other organs. In the liver,  the intravascular  deposits  were found in the sinusoids  and in 
the  hepatic  veins.  It  was quite  common to see  thrombi in  the central  veins  extending into  the 
intralobular  hepatic veins as rounded masses of fibrin  containing trapped leukocytcs and a 
few red blood cells.  The areas of necrosis  wcrc generally  in the central  portion of the liver 
WBC (IN THOUSANDS/c.mm.) 
16, 
12 
8 
4  ¸ 
CONTROL 
.....  SINGLE  INJECTION 
TWO  INJECTIONS 
ENDOTOXIN  I.V.  ENDOTOXIN  I.V. 
HOURS 
Fro.  1. Changes in circulating leukocytes. 
4"8 
TABLE II 
Circulating  Leukocytes  in  Thousands  per  c.mm. 
Hrs  ........  0  1  4  24  25  28  48 
Mean°. 
Range.  " (3.74_'s3.s) 
Control series (7 animals) 
3.9  (3.4.4  5.1  4.4  144"8  t  5.0 
(3.0-4.6)  1-5.3)  (4.1-6.2)  (3.7-5.6)l(4.0-5.7)1(3.9-5.7) 
Mean.. 
Range. 
One injection (11 animals) 
1.3  1.3  [  5.3 
(0.8-1.9)  (0.2-3.1)  (5.4-7.9) 
5.6  I  7.5  I 
(One sample each) 
8.9 
Two injections (16 animals) 
Mean  ]  4.5  T  1.8  '  1.4  ]  7.4  ....  2.8  3.3  8.2 
Range...[  [  l  1(3"1-5"4)  (0.9-3,4)  (0.6-2.9)  (4.8-11.3)(0.9-6.9)  (1.2-5.8)(3.5-14.0) 
Iobule hut often extended into the periportal  region and sometimes involved a portion  of a 
Iobule or even several adjacent  Iobules. In the spleen, the intravasculax deposits were found 
in the sinnsoids of the red pulp and never in the Malpighian corpuscles. In the kidney, the 
deposits appeared primarily in the glomerular capillaries. Only a few cases exhibited artetiolar D.  G.  McKAY AND S.  S.  SHAPIRO  357 
or venular  thrombi.  When necrosis occurred it presented  the appearance  of bilateral  renal 
cortical necrosis. In order to compare the extent of the thrombosis with the extent of the al- 
terations in the circulating coagulation factors, the organs were graded from 0 to 4+, based 
on the relative number of thrombi in the small vessels. Table I indicates the extent, location, 
and incidence of thrombi in the various organs. 
Thrombi  appeared  following the first injection but the thrombosis was present  in fewer 
animals and was much less extensive than in animacs reeeiv!ng two injections. Although the 
PLATELETS 
( IN THOUSANDS/c. ram.) 
400 
300' 
200 
IO0 
......  CONTROL 
I.l  SINGLE  INJECTION 
,re,liB=  TWO  INJECTIONS 
.....---''"" 
--'J"x_. 
--"  =  o 
ENOOTOX~N  ~.V.  ENDOTOX~N  t~ 
HOURS 
FIG. 2. Changes in circulating platelets. 
4~ 
TABLE III 
Circulating  Platelets  in  Thousands  per  C.  ram. 
Control series (8 animals) 
Mean  ~  ....  235  (212608)  6-35  2611254[  238  224  287 
Range..  (165-344)  (216-336)  (208-308)  (218--286)  (188-254)  (184--416) 
One injection (11 animals) 
Mean  ....  319  t73  I  184]  1971217  '  1831173 
(56-285)  (63-341)  (148-226)  sample  Range.  (190-564)  (One  each) 
Two injections (16 animals) 
Mean  ....  3011195  xs7  I  144  90  ]  73[  76 
Range...  (198-500)  (59-386)  (48--344)  (37-286)  (30-270)  (30-243)  (29-188) 358  BACTERIAL  ENDOTOXIN  AND  BLOOD COAGULATION SYSTEM.  I 
relative incidence of splenic thrombi was the same in both groups, two injections of bacterial 
endotoxin doubled, or more than doubled the inddence of thrombi in lungs, fiver, and kidneys. 
In addition there were quantitatively more thrombi in  the involved organs in the two injec- 
tion animals. 
TIME (MINUTES) 
40 
I I 
52, 
24, 
16' 
......  CONTROL 
TWO INJECTIONS 
8, 
ENDOTOXIN  IV.  ENDOTOXIN  I.V. 
HOURS 
FIG. 3. Whole blood coasu]ation time. 
TABLE  IV 
Whole Blood  Coagulation  Time  (in Silicone) in Miuute~ 
""  ................  t  o  '  '  I  ~'  ~,  .I. 
Controls (6 animals) 
Mean .........  30  31  36  [  35  37  34,  36 
Range .........  (16-34)  (12--44)  (27-44)  [  (24-45)  (30-48)  (23--46)  [  (20-51) 
One injection (12 animals) 
Mean .........  28  32  19  ........................................... 
Range .........  (18-54)  (13-66)  (11-32) 
Two injections (15 animals) 
Mean ........  :31  33118  30126  17129 
Range ........  (18-41)  (20-55)  (12-36)  (11-62)  (12-74)  (12-22)  (12-52) D.  G.  McKAY AND S.  S.  SHAPIRO  359 
Circulating Leukocytes.--Table II  and Fig.  1 illustrate  the changes in the 
circulating leukocytes during the  48  hour period  of observation.  The drop 
in circulating leukocytes after each injection can be related to the histologic 
observation that the granulocytes are sequestered in the pulmonary and hepatic 
rag. FIBRINOGENI I00 mL 
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FIG. 4. Changes in circulating fibrinogen. 
4~ 
TABLE V 
Fibrinogen in Mg./lO0 M1. 
Hrs ........  0  I  I  I  ~,  [  24  I  25  1  28  ]  48 
Controls (9 animals) 
Mean  ....  215  216  196  281  248  (129-332432)  253 
Range...  (176-272)(161-275)  (144-251)  (194-364)  (140-349)  (167-319) 
One injection (11 animals) 
Mean  ....  275  249  226  530  473  [  474  784 
I 
(474)  Range..  (194-477)(204-282)  (134-270)  (517-624)  (422-524)  (4,30-1500) 
Two injections (12 animals) 
]  (332-603)  (379-623)  304  (5Z25) 
Mean  ....  233  209  203  465  484  ' (!06-490) 
Range...  (168-322)  (147-258)  (164-243) FIBRINOGEN (rag.%) 
700. 
600. 
500. 
400' 
300, 
200. 
I00 
--',  .-~  V 
NO  RENAL  THROMBI 
RENAL THROMBI  PRESENT 
m  I  a i  i  1'  4  2t,~  2s 
ENOOTOX,,  ,.~.  ENOOTO~,N  ,.~. 
HOURS 
FzG. 5. l~bfinogen levels with and without renal t]~ombi. 
46 
FIBRINOGEN  (toO. %) 
400. 
300. 
200, 
I00' 
.....  CONTROL 
INCUBATED SAMPLE 
ENDOTOXIN  I.V.  ENDOTOXIN 
HOURS 
Fzo. 6. Fibrinogenolysis. 
I.V. 
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vessels during  these  brief periods.  They appear  to be subsequently released 
into the circulating blood. Only one animal was followed during  the  second 
24 hours in the one injection series. The degree of change in circulating leuko- 
cytes could not be related to the degree of pathologic alteration in individual 
CaseS. 
16 
'¢3  t- 
O 
(n 
~D 
._e 
I-" 
E 
2  e- 
O. 
12 
8- 
....  Control 
Two Injections 
I  1  II  I  I 
Hours  ~1  4  24 25 28  48 
T  t 
Endotoxin  W.  Endotoxin  I.V, 
FIG. 7. One stage prothrombin times. 
TABLE VI 
Protkrorabin Times in Seconds 
Hrs...  0  [  I  !  4  .....  24  25128148 
Controls (4 animals) 
Mean  ....  8.6  9.1  8.4  8.8  7.2  8.1  7.7 
Range...  (7.6-9.5)  (7.9-10.0)(7.5-9.3)  (8.2-9.7)  (6.2-8.0)(6.5-9.2)  (6.8-8.4) 
Two injections (12 animals) 
• .I  7.7  7.5  7.9  7.0  7.4  8.6  7.3 
Mean..  I  (6.5-9.2)  (6.1-8.9)  Range..  (6.8-9.6)  (6.9-9.7)  (6.2-9.4)  (7.2-11.0) (7.3-9.4) 
Circulating  Platelets.--Table  III and Fig.  2  indicate that  the platelets de- 
crease after the first injection, and to a  lower level after the second injection. 
As in the white blood cell count there was no direct correlation of the degree 
of platelet response with the extent of anatomic change. 
Whole Blood Coagulation  Time.--Table IV and Fig. 3 reveal the shortening 
of the  coagulation time in  silicone 4  hours following each  injection and  the 
subsequent return to normal 24 hours after each injection. 362  BACTERIAL  ENDOTOXIN AND  BLOOD  COAGULATION SYSTEM.  I 
Fibrinogen.--The  alterations in  circulating fibrinogen levels  are  presented 
in Table V and Fig. 4. The fibrinogen levels in the control animals remained 
almost constant except for a slight decrease during each 4 hour period following 
the injection of saline. Since 8 to 10 ral. of blood were removed just prior to 
this period,  hemodilution may account for these apparent  drops.  They can- 
not be construed as evidence of intravascular dotting, since no fbrin thrombi 
were observed in these animals. The most striking changes are the elevations 
ANTITHROMBIN  TIME 
(SECONDS) 
20 
.....  CONTROL 
TWO  INJECTIONS 
~I  200~250f 
4 
ENDOTOXIN  LV.  ENDOTOXIN  I.V. 
HOURS 
Fzo. 8. Antithrombin times. 
i  ii[ 
48 
TABLE VII 
Thrombin Clotting Times in Seconds 
I 
Hra  ......  0  1  4  [  24  25  48  28 
Controls  (4 animals) 
Mean....  14.2  15.9  17.5  11.7  11.9  11.9  12.8 
Range...  (12.9-16.0)  (15.5--17.3)  (16.0-18.6)  (11.5-12.0)  (10.2-13.6)  (10.9-13.9)  (11.6-14.8) 
Two injections (12 animals) 
Mean  ....  14.5  14.4  15.1  12.5  13.4  13.9  13.? 
Range...  (11.?-19.~)  (12.6-16.1)  (11.9-17.9)  (11.5-13.6)  (11.2-15.6)  (9.9-22.0)  (13.1-15.0) D.  G.  McKAY  AND  S.  S.  SHAPIRO  363 
of the fibrinogen levels 24 hours after the first injection of toxin and the sharp 
decrease  in  fibrinogen after  the  second  injection in  animals developing the 
generalized Shwartzman reaction. This drop in fibrinogen occurs during the 
period  when the fibrin  thrombi  develop histologically in  the kidney. When 
the amount of thrombosis on a  histologic basis was compared with degree of 
fibrinogen drop  after  the  second  injection of  toxin,  a  close  agreement was 
found. 
The  injection of  two  spaced  doses  of endotoxin did  not  always produce 
glomerular thrombi within the 48 hour period. The fibrinogen levels in such 
animals are presented in Fig. 5 and are compared with those that did develop 
renal  lesions.  The very slight drop in fibrinogen in those animals that were 
free of renal thrombi was of the same order as the drop in the controls and 
may also have been due to hemodilution. 
Fibrinolysis  and  Fibrinogenolysis.--The  possibility  that  the  observed  de- 
creases  in  circulating  fibrinogen might  be  due  to  activation  of  circulating 
fibrinolytic or fibrinogenolytic enzymes required an answer. None of the whole 
blood clots incubated for 48 hours showed any evidence of lysis. When ali- 
quots of plasma samples used in the fibrogen determination were diluted with 
buffered saline and incubated for 2  hours at 37°C.,  no significant difference 
was noted when the two fibrinogen levels were compared. The fibrinogen levels 
before and after incubation are presented in Fig. 6. 
Prothrombin  Times.---One  stage prothrombin times on blood taken during 
the course of the generalized Shwartzman reaction are presented in Table VI 
and Fig. 7. There does not appear to be a  significant difference between the 
controls and the injected animals. 
Thrombin  Clotting Times.--In  addition  to  the  whole  blood  coagulation 
times, thrombin clotting times were measured to test for the possible develop- 
ment of anticoagulant activity during the generalized Shwartzman reaction. 
The results obtained using 150 #g. of bovine thrombin are presented in Table 
VII and the results with 150, 200, and 250 #g. are presented in Fig. 8. There 
is no significant difference between the controls and the toxin-treated animals. 
DISCUSSION 
These findings demonstrate that when bacterial endotoxins gain access to 
the  blood stream in  the proper  dose range  they have a  profound effect on 
certain dements of the blood coagulation system. With one exposure to endo- 
toxin there is a progressive elevation in the circulating fibrinogen for 48 hours 
to a  level more than twice the normal. The mechanism of the increase is not 
known but presumably represents an increased rate of release or production 
from the liver. With a  second injection 24 hours after the first, there was an 
abrupt decrease in fibrinogen in animals exhibiting the renal thrombi of the 
generalized  Shwartzman  reaction.  This  confirms  for  bacterial  endotoxin 364  BACTERIAL  ENDOTOXIN  AND  BLOOD  COAGULATION  SYSTEM.  I 
the effect noted by Thomas (7)  after the injection  of liquoid and endotoxin. 
Because the drop occurs at the time that thrombi are formed on a histologic 
basis, it seems likely that these  thrombi are derived  from fibrinogen and are 
therefore composed of fibrin. When the thrombi do not appear in the kidney 
g!omeruli, the drop in fibrinogen does not occur.  The decrease in fibrinogen 
cannot be  attributed  to  enzymatic destruction  since  in  these  experiments 
there was no evidence of fibrinolytic  or fibrinogenolytic  activity in the  ani- 
mals' blood. 
In attempting to unravel  the problem  of what constitutes "preparation" 
for the generalized Shwartzman reaction or the basic reason for the difference 
in extent of thrombosis  between  the first  and the second injections,  several 
questions  are  raised  by the results  obtained thus far. On  a  histologic basis 
the difference between the first and second injection  is twofold:-- 
(a)  The  incidence  and  extent  of  lung  and  liver  thrombi  are  increased 
(doubled) by the second injection, and 
(b)  Renal thrombi appear usually only after the second injection. One of the 
most notable hematologic  differences in existence at the time of the second 
injection is the fact that the fibrinogen level is twice as high as it is at the time 
of the first injection.  This suggests  that the more extensive  thrombosis  fol- 
lowing the second injection  may be  due to the presence of greater amounts 
of fibrinogen. In conformity with this hypothesis it is interesting to note that 
the two animals developing renal thrombi after only one injection had higher 
fibrinogen levels to start with (by approximately 100 mg. per cent)  than the 
remainder of the control  animals. 
Two other factors have been  altered by the time of the second injection, 
namely an  increase  in  circulating  leukocytes  and  a  decrease  in  circulating 
platelets.  As  has  been  previously  noted,  the extent  of  thrombosis was  not 
directly related to the extent of thrombocytopenia or leukocytosis in individual 
animals.  The fate of the platelets is not entirely settled.  It seems clear  that 
some are  clumped  and caught in the pulmonary vessels since they are seen 
in this location in the sections. Stetson (10) has demonstrated that endotoxins 
cause  a  clumping  of platelets in  dvo.  The fact  that  the  thrombocytopenia 
persists  after both  injections  suggests  that many are  destroyed after being 
dumped.  If platelets are  destroyed and their clot-promoting  substance  re- 
leased into the plasma,  the possibility  that they may be responsible for ini- 
tiating the disseminated  intravascular thrombosis  must be considered. 
The role of the leukocytes in this reaction has received considerable atten- 
tion. They appear to play an important part since the production of leuko- 
penia,  by  pretreatment  with  nitrogen  mustard,  prevents  the  generalized 
Shwartzman reaction  (11-14).  Endotoxins are  taken up  by  the  circulating 
leukocytes within 15-30 minutes and the blood is cleared of endotoxin within 
this time (15-17).  In  vitro  studies  have shown that endotoxin-treated leuko- D.  G. McKA¥  AND  S. S.  SHAPIRO  365 
cytes (a) disintegrate at a  rate 4-5 times that of normal leukocytes (18),  (b) 
clump and adhere to each other (18),  (c) do not migrate on slides or in tissue 
culture preparations as normal leukocytes do (18, 19), and (d) release lysozyme 
into  the  surrounding  medium  (20).  The  possibility  that  a  clot-promoting 
agent may be released from damaged leukocytes in the  generalized  Shwartz- 
man reaction must be considered.  It is clear from the studies reported herein 
that  leukopenia occurs during  both periods of thrombosis and that  the more 
extensive thrombosis following the second injection is preceded by an elevation 
of circulating  leukocytes. 
Although  the whole blood coagulation  time is shortened  after each intra- 
venous injection of toxin, it returns to normal by the time of the second injec- 
tion and therefore cannot be considered,  even in a general  sense, a  "prepara- 
tory" phenomenon.  However, since the shortening occurs during both periods 
of fibrin  deposition,  the  two phenomena  may be related.  It may be that  a 
partial  polymerization of fibrinogen  has  already been achieved in  vivo,  and 
with fewer steps to go through in ~itro, the time required for clotting is less. The 
"heparin-precipitable  protein"  described  by  Thomas  (21)  may  represent 
another manifestation of such an altered fibrinogen. 
From  the  hematological  standpoint  "preparation"  for  the  generalized 
Shwartzman  reaction  is accompanied by an increased  circulating  fibrinogen, 
leukocytosis, and thrombocytopenia. The actual mechanism by which  any or 
all of these changes react to produce the phenomenon remains to be elicited. 
It  is  useful  to  compare  the  disseminated  intravascular  thrombosis  found 
in the Shwartzman  reaction with disseminated thrombosis induced by agents 
other than bacterial endotoxins.  Tissue thromboplastin has been used experi- 
mentally in extensive studies by Schneider  (22). This agent in large quantities 
induces sudden death with extensive pulmonary vascular thrombi. With sub- 
lethal amounts some animals exhibited cerebral and hepatic hemorrhages and 
areas  of necrosis.  Four major  differences  exist  between the  effects  of tissue 
thromboplastin  and  bacterial endotoxin injected intravenously:-- 
(a)  The  amount  of bacterial  endotoxin used is considerably less  than  the 
amount of thromboplastin. 
(b) Thrombosis occurs within a few minutes after thromboplastin  injection 
but over a period of several hours with bacterial endotoxin. 
(c) Thrombi appear predominantly in  the lungs  and veins and not  in  the 
kidneys following  thromboplastin,  but  predominantly  in  the  kidneys,  liver, 
spleen, and lungs after bacterial endotoxin. 
(d) Bilateral renal cortical  necrosis has not been found after thromboplastin 
injection. 
These  differences  indicate  that  although  both  these  reagents  cause intra- 
vascular thrombosis they do so by different  mechanisms. 
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intravascular  thrombosis  (23-25).  As  in  the  experiments  using  thrombo- 
plastin, the amount of clot-promoting agent was far greater than the amount 
of endotoxin used.  The  response  of  the  hemostatic mechanism to  the  clot- 
promoting agent released from red blood cells in another animal species,  was 
in some ways similar to but in others different from, the response to bacterial 
endotoxin. The two reactions share in common an immediate drop in leuko- 
cytes  and  platelets,  an  initial  decrease  in  coagulation  time,  a  decrease  in 
circulating  fibrinogen,  and  no  evidence  of  fibfinolysis or  fibrinogenolysis. 
However,  in  the  incompatible  transfusion  reaction  the  coagulation  time 
became  prolonged  after  several  hours,  a  circulating  anticoagulant  activity 
appeared, and the prothrombin times were prolonged. It is not certain as to 
whether these represent  differences in  species  response or differences in  the 
agents used to induce thrombosis. Nevertheless, these histological and hemato- 
logical comparisons suggest that bacterial endotoxins do not act in the same 
manner as tissue thromboplastin. 
SUMMARY  AND CONCLUSIONS 
The  intravenous  injection of bacterial endotoxins  alter the  coagulation 
system of rabbits' blood in ~/vo.  Twenty-four hours after the first  injection 
the fibrinogen level  rises  to twice normal values. The second injection  at this 
time causes a 30 to 40 per cent decrease in fibrinogen content in 4 hours. 
Twenty hours later  it again rises  to twice normal values. A  marked decrease 
in whole  blood  coagulation times  in silicone occurs  4  hours  after both 
injections but  rises to normal  values  24  hours  following each  injection. 
The  circulating platelets drop  from  average  levels of  300,000/c.mm.  to 
150,000/c.mm. after  the first  injection.  The platelets  remain at this  low level 
and decrease to less  than I00,000 after  the second injection.  During this  time 
no fibrinolytic  or fibrinogenolytic  activity can be detected. Also, there is no 
significant  change in the one stage prothrombin times or antithrombin  titres. 
The marked decrease in circulating  fibrinogen  at the time when intracapil- 
lary  thrombi are formed suggests  that the "hyaline" thrombi of the generalized 
Shwartzman reaction  are composed, in part,  of fibrin. 
There appears to be a relationship  between the level  of circulating  fibrinogen 
at the time of injection  of bacterial  endotoxin and the extent of the thrombo- 
sis. The higher the preinjection fibrinogen level, the more extensive is the 
thrombosis. There is also a relationship between  the amount  of fibrinogen 
loss  and the extent of thrombosis after  the injection.  The more extensive the 
thrombosis the greater is the postinjection  decrease in circulating  fibrinogen. 
A  comparison between the response of the hemostatic mechanism  to tissue 
thromboplastin  and bacterial endotoxin  indicates that the latter acts in a 
unique manner and not by way of a simple "thromboplastic"  activity. 
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Shwartzman reaction is accompanied  by  an increased circulating fibrinogen, 
leukocytosis, and thrombocytopenia. 
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